Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-024384
Filing Date
2025-08-15
Accepted
2025-08-15 16:30:30
Documents
1
Period of Report
2025-08-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3799
  Complete submission text file 0001641172-25-024384.txt   5542
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Crombez Eric (Reporting) CIK: 0001653052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 251225116